38 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
the participant’s death, (ii) transfer an award to a former spouse as required by a domestic relations order incident to a divorce, or (iii) otherwise transfer
8-K
EX-3.1
5of prarh3mxn8990
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
PRE 14A
8h159r
1 Sep 21
Preliminary proxy
4:46pm
8-K
EX-1.1
z3fhj200r z0aprlx
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
424B3
05q40pw93 rz7x
12 Apr 21
Prospectus supplement
1:44pm
S-3
naj0e4t
2 Apr 21
Shelf registration
12:00am
8-K
EX-10.1
b9vuad bymgs2o
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am